Cholesterol affects cancer cell signaling pathways, such as NF-kB [28], oxysterol-binding protein-like protein three [29], R- Ras/Akt [29], HMGCR [30], and Ar inhibitors [31], and so on, thus promoting chemotherapeutic drug resistance in GC. This evidence concerns the gene AKT1 and cancer.